.jpg)
.png)
Spring 2023
This issue is sponsored by the Southwest and Pacific Lipid Associations
Happy New Year to All! On behalf of co-editor Dr. Kaye-Eileen Willard and myself, I wish to thank those of you who have contributed to the outstanding issues of LipidSpin during the last year and look forward to the education and clinical insights provided by NLA members in 2023. I’m excited about... more
Visionary. Pioneer. Trailblazer. Inventor. Innovator. Boundary pusher. Those who push past what is for what can be. Pushing Boundaries, the theme for this edition of LipidSpin, was inspired and informed by our members and members of the lipid community as we collectively move past a time of... more
“The problem with heart disease is that the first symptom is often fatal.” - Michael Phelps As an Acute Care Nurse Practitioner specializing in cardiac surgery and interventional cardiology, I have heard far too often from my patients with acute coronary syndrome, as they were... more
The NLA now includes > 2,000 members with representation from physicians, NP/PAs, clinical pharmacists, dietitians, and other healthcare professionals. In this Clinical Feature, we highlight the many ways in which our SWLA/PLA members are pushing boundaries in Clinical Lipidology. Across the NLA... more
“If we wait for the appropriate time to start working, we shall never work; it is better to start with the available means and let the next generation continue what we started”. - Mutaz Al-Khnifsawi, MD Situation Familial hypercholesterolemia (FH) is a common genetic lipid... more
Introduction It’s been over 20 years since the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial1 ushered in the initiation of aggressive LDL-C lowering therapy before hospital discharge for acute coronary syndrome (ACS). Three years later, the Intensive versus... more